HLB Genex announced on June 16 that it has appointed Dr. Kim So-young as its new Vice President to strengthen its global healthcare business.
Dr. Kim is an expert with over 20 years of experience in bio research and development (R&D) and commercialization at CJ CheilJedang. She began her career at CJ CheilJedang's Bio Research Institute and has held key positions, including head of the Amino Acid Research and the Animal Nutrition (AN) division.
Recognized for her R&D capabilities and outstanding business performance, Dr. Kim was appointed as the first female internal director at CJ CheilJedang. She contributed to achieving the highest quarterly operating profit in the bio sector in the second quarter of 2021 while leading the animal nutrition business.
During her tenure, she played a crucial role in securing competitiveness in the global amino acid market, particularly in lysine and tryptophan, by overseeing both practical and managerial aspects.
With this new appointment, HLB Genex plans to accelerate the development of high-value protein and peptide materials using synthetic biology and precision fermentation technologies, building on its existing industrial enzyme business. The company also aims to expand into the medical food, personalized nutrition, and anti-aging bio solutions markets.
The company expects Dr. Kim's commercialization and scaling-up capabilities to play a vital role in enhancing HLB Genex's business sophistication and securing new growth engines.
An HLB Genex representative stated, "Dr. Kim's core strength lies in her proven ability to translate R&D achievements into actual business outcomes. We aim to drive substantial revenue growth in high-value healthcare material markets such as medical food and anti-aging."
Meanwhile, HLB Genex reported a consolidated revenue of 11.7 billion won in the first quarter of this year, a 9.3% increase compared to the same period last year. The company's operating profit reached 1 billion won, marking a 25% increase year-over-year, driven by a sales strategy focused on high-value products and cost reduction efforts.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.